Opus Biotech Comm

Investor Relations, Public Relations and Marketing Services for Life Sciences Companies. Founded by industry vets Daniel Eramian and Charles S. Craig

[Diakonos Oncology @DiakonosOnc]

@DiakonosOnc to present poster at #AACR24 on Dendritic Cell Vaccine #immunotherapy for #GBM. Therapies have generated encouraging efficacy and safety in clinical trials to date. Company leadership will be available for meetings. @AACR #cancerresearch #cancer #biopharma

[Nanoscope Therapeutics @NSTherapeutics]

Great news for @NSTherapeutics team. This @NatEyeInstitute @NIH grant will advance our #genetherapy for Age-Related Macular Degeneration
#AMD #opthalomology #retina

https://t.co/SE7Erzseqv

[Opus Biotech Comm @Opus_Biotech]

Great news in the fight against #HIV #AIDS @hdtbio @NIH @NIAIDFunding #vaccines

[HDT Bio @hdtbio]

@hdtbio excited to move toward a vaccine for #HIV-1 with a 3-year grant from @NIH #NIAID. Congrats @KhandharAmit Dir. of Formulation, the PI on this award, and to our LION team for all their hard work. #aids #publichealth #VaccinesWork https://t.co/hoswkQHvEg

[HDT Bio @hdtbio]

@hdtbio #vaccines #COVID19 #COVIDSecondWaveInIndia https://t.co/2ZEUvyw4yD

[Opus Biotech Comm @Opus_Biotech]

Exciting developments to ultimate make #CovidVaccine available to more people.

[HDT Bio @hdtbio]

@hdtbio is featured in @ScienceMagazine on the challenge of making #COVID19 vaccines with less refrigeration requirements to better serve populations across the globe where refrigeration is in short supply. #COVID19 #covid19vaccine #mrnavaccines
https://t.co/J5cQJKoYJR

[Opus Biotech Comm @Opus_Biotech]

Outstanding additions to this company that is doing great things!

[Nanoscope Therapeutics @NSTherapeutics]

@NSTherapeutics announces new clinical advisory board including Michael Singer, MD; Stephen H. Tsang, MD, PhD; Paul Yang, MD, PhD; and Srinivas R Sadda. #retinitispigmentosa #stargardsdisease #AMD #genetherapy #rarediseases #optogenetics https://t.co/x8snjz8MC7

[Opus Biotech Comm @Opus_Biotech]

Great new technology from @hdtbio in this interesting article.

[HDT Bio @hdtbio]

MIT @techreview recently featured @hdtbio CSO Darrick Carter on how HDT's #mRNA #Covid-19 technology can overcome the storage and distribution challenges of current vaccines in use which limit access in developing nations. Read it here: https://t.co/GjmpeIQ6GO #VACCINES

[Opus Biotech Comm @Opus_Biotech]

Exciting new research! #photonicswest

[Nanoscope Therapeutics @NSTherapeutics]

@NSTherapeutics is at @PhotonicsWest with multiple presentations featuring groundbreaking research in optical gene delivery and opsin-based neuromodulation therapy. @SPIEtweets for details: #https://prn.to/3rnttp3 #optogenetics #genetherapy

[HDT Bio @hdtbio]

@hdtbio announces additional $3M as part of seed financing round led by @ZoicCapital for a total raise of $6M. Funds support advancing 3 lead products into clinical trials this year. Details: https://t.co/Cr8jtBvltR #immunotherapy #oncology #vaccines #biotech

[Opus Biotech Comm @Opus_Biotech]

@Opus_Biotech is pleased to partner with @CxPrecisionM, a biotech company developing blood-based diagnostics for early assessment and treatment of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. https://t.co/kvjZ22OtZw #Alzheimers #Parkinsons

[Opus Biotech Comm @Opus_Biotech]

Really exciting news about a promising treatment for #pancreaticcancer #pancan #cancertreatment #clinicaltrials

[NanOlogy LLC @NanOlogyLLC]

@Nanology announces first patient enrolled in expansion of #pancreaticcancer #clinicaltrial. More Details: https://t.co/zrzJwFAPTJ

[Opus Biotech Comm @Opus_Biotech]

Great news from @NanOlogyLLC about their #bladder cancer program. Check https://t.co/NsyzB4mnoQ for info about programs for #lung cancer #prostatecancer #pancreaticcancer and more. Very interesting and promising.

[NanOlogy LLC @NanOlogyLLC]

@NanOlogyLLC Bladder Cancer Trial Enrollment Progress!
We are very excited by the therapeutic potential of NanoDoce in #bladdercancer. Read more:
https://t.co/jOTg9Soxzz
#cancer #clinicaltrial #CancerResearch

[NanOlogy LLC @NanOlogyLLC]

@NanOlogyLLC to SF for #JPM2020. Now setting mtgs w/potential partners & investors to discuss clinical progress of our therapeutic drug platform in gastrointestinal, genitourinary, peritoneal, lung & other cancers. Contact [email protected]
https://t.co/Dk7B23j8Pg #pancan

[Kineta @kinetabio]

https://t.co/wABXprU5nu

[Opus Biotech Comm @Opus_Biotech]

Go Heather Giles!

[Vapogenix Inc @vapogenix]

Vapogenix attended the Texas Life Science Forum 2019. Wonderful event! Kudos to the organizers.
#TLSF2019 @BioHouston @ricealliance

[Opus Biotech Comm @Opus_Biotech]

Exciting news for patients

[Vapogenix Inc @vapogenix]

Today announced results of Phase II trial of our lead product, VPX638, a topical non-opioid, lidocaine-free analgesic. Data reveals VPX638 significantly reduces pain and use of opioids. Read more: https://t.co/8U012aAYXR #opioidcrisis #painrelief #painmanagement

[Opus Biotech Comm @Opus_Biotech]

Great opportunity to hear from Houston-based @Vapogenix

[Vapogenix Inc @vapogenix]

Vapogenix is presenting at the Texas Life Science Forum in Houston on Wednesday November 6th, 2019
"Uncovering Strategies for Planning and Executing a Clinical Trial in Australia"
#TXLSF #Pain #Australiaclinicaltrials

[Opus Biotech Comm @Opus_Biotech]

about

[Opus Biotech Comm @Opus_Biotech]

@BioNorthTX - doing the good work!

[BioNorthTX @BioNorthTX]

We love meeting our member and partners! Especially when it is over coffee. :) Come join us tomorrow at @TECHFortWorth for coffee and networking.
https://t.co/vtnJgbkQBo

[Opus Biotech Comm @Opus_Biotech]

Great tip for anyone in Toronto tomorrow!

[Alliance for Artificial Intelligence in Healthcare @theaaih]

@theaaih President & Co-Founder Annastasiah Mudiwa Mhaka, PhD in Toronto tomorrow 4/3 for @MaRS Healthkick Invest, part of #HIW2019. Catch up with her on 4/3 at the panel on #AI and #BigData: Therapeutics. https://t.co/nO1SfyvRt6